Sign up for our eNewsletter
[f] [t] [in] [blog]

Portfolio Companies

Clean Technology
Information Technology
Medical Device

Dura Biotech

About: Some 17,000 people, mostly children and senior citizens, cannot have life-saving heart valves implanted because the available options are too large. Dura Biotech’s key innovation is a thinner heart valve—specifically, a transcatheter aortic valve that is 33% smaller than anything on the market. Dura Biotech’s implant can be delivered through an artery in the leg rather than the heart, eliminating the need for open-heart surgery, a procedure that is risky for many patients and has a long recovery time.

Contact: Eric Sirois


CI Representative:
Patrick O’Neill
Director, Investments